New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

PINKvsFTXHETF Comparison

ETF 1
PINK

Simplify Health Care ETF

This fund is part of
Healthcare Technology
-1.76%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.99%

Simplify Health Care ETF (PINK) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. PINK's top 3 sector exposures are Healthcare, Non-Energy Materials and Consumer Cyclicals. In contrast, FTXH's top sector exposures are Healthcare. PINK is less expensive with a Total Expense Ratio (TER) of 0.51%, versus 0.6% for FTXH. PINK is up 4.94% year-to-date (YTD) with -$41M in YTD flows. FTXH performs better with 27.11% YTD performance, and +$1.01B in YTD flows. Run a side-by-side ETF comparison of PINK and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PINK vs FTXH performance and flow charts

Performance

-2.0-1.00.01.02.03.0%Sep 16Sep 23Sep 30Oct 7Oct 14

Cumulative Flows

-50 M0 M50 M100 MSep 16Sep 23Sep 30Oct 7Oct 14

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/16/2026
1M3MYTD1Y3Y5Y
Perf.
PINK
FTXH
-0.96%+2.19%
-1.60%+8.28%
+4.94%+27.11%
+17.36%+45.11%
+54.67%+67.72%
+56.86%+75.07%
Flows
PINK
FTXH
-$40M+$34M
-$56M+$982M
-$41M+$1.01B
+$106M+$1.01B
+$201M+$1.01B
+$262M+$1.01B
Volatility and drawdown
3M1Y3Y5Y
Volatility
PINK
FTXH
+16.72%+18.80%
+18.17%+17.38%
+17.32%+17.15%
+17.62%+16.43%
Max drawdown
PINK
FTXH
-6.78%-5.45%
-16.68%-7.50%
-18.81%-19.32%
-18.81%-19.32%
Max drawdown duration
PINK
FTXH
58d52d
154d99d
390d393d
390d393d
Trading data

Create an account to view trading data

Join for free
PINK
FTXH
Last sale
10/16/2026 at 7:53 PM
$38.08
$41.65
Previous close
10/16/2026
$38.85
$41.97
Consolidated volume
10/16/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

PINK
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PINK
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/16/2026 at 7:53 PM
Live
Closed
PINK
FTXH
Last price
$38.08
$41.65
1D performance
-1.98%
-0.76%
AuM$314.74 M$1.11 B
E/R0.51%0.6%
Characteristics
PINK
FTXH
Management strategyActivePassive
ProviderSimplifyFirst Trust
Benchmark-NASDAQ US Smart Pharmaceuticals Index
N° of holdings5149
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 7, 2021September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

PINK
USA
92.56%
Other
7.44%
FTXH
USA
95.82%
Other
4.18%

Sectors

PINK
Healthcare
85.34%
Other
14.66%
FTXH
Healthcare
99.79%
Other
0.21%
Advertisement

Diversification

PINK

Total weight of top 15 holdings out of 15

74.61%
FTXH

Total weight of top 15 holdings out of 15

67.15%

Top 15 holdings

Data as of August 31, 2026
PINK
Eli Lilly & Co.
10.22%
Humana, Inc.
6.99%
Purecycle Technologies, Inc.
6.12%
Thermo Fisher Scientific, Inc.
5.09%
Johnson & Johnson
4.98%
Jazz Pharmaceuticals Plc
4.90%
AbbVie, Inc.
4.70%
UnitedHealth Group, Inc.
4.47%
Henry Schein, Inc.
4.43%
United Therapeutics Corp.
4.41%
Warby Parker, Inc.
4.19%
Avantor, Inc.
3.84%
Benitec Biopharma, Inc.
3.60%
Quest Diagnostics, Inc.
3.34%
Gilead Sciences, Inc.
3.32%
FTXH
Merck & Co., Inc.
7.62%
AbbVie, Inc.
7.05%
Eli Lilly & Co.
6.92%
Johnson & Johnson
6.87%
Bristol Myers Squibb Co.
6.75%
Amgen, Inc.
3.56%
Biogen, Inc.
3.54%
Viatris, Inc.
3.51%
Vertex Pharmaceuticals, Inc.
3.48%
Regeneron Pharmaceuticals, Inc.
3.33%
Cardinal Health, Inc.
3.29%
Pfizer Inc.
3.25%
Gilead Sciences, Inc.
3.16%
Incyte Corp.
2.43%
United Therapeutics Corp.
2.39%
Frequently asked questions about PINK and FTXH

How have the PINK and FTXH ETFs performed in 2026?

As of October 16, 2026, PINK is up 4.94% year-to-date (YTD), while FTXH has returned 27.11%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: PINK or FTXH?

Year-to-date, the PINK ETF saw -$41M in flows, compared to +$1.01B for FTXH.

Which ETF is more volatile: PINK or FTXH?

Over the past year, PINK had a volatility of 18.17%, while FTXH experienced 17.38%.

Which ETF is bigger: PINK or FTXH?

As of October 16, 2026, PINK holds $314.74 M in assets under management (AUM), while FTXH manages $1.11 B.

What sectors do the PINK and FTXH ETFs invest in?

PINK leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the PINK ETF and FTXH ETF?

PINK top holdings include Eli Lilly & Co., Humana, Inc. and Purecycle Technologies, Inc.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

Which ETF is more diversified: PINK or FTXH?

PINK holds 51 securities with 74.61% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 67.15%.

Advertisement
Latest news about PINK & FTXH
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.

Global ETF Survey 2026